diabetic foot
Diabetic foot refers to a disease state in which ulcers and gangrene occur in the feet of diabetic patients due to neuropathy, which reduces the protective function of the lower limbs, and macrovascular and microvascular lesions, which cause insufficient arterial perfusion and microcirculatory disorders. Diabetic foot is a serious complication of diabetes and one of the important causes of disability and even death in diabetic patients. It not only causes pain to patients, but also adds a huge economic burden to them.
-
Site of disease:
Foot -
Infectious :
Not contagious -
Frequent population:
Diabetic patients -
Related symptoms:
Muscle atrophy insensitivity dry skin intermittent claudication plantar ulcer
Related Drugs
repaglinide tablets
Indication: It is used for patients with type 2 diabetes (non-insulin-dependent) whose high blood sugar cannot be effectively controlled by diet control and exercise. Repaglinide tablets can be used together with metformin. Compared with the use of each alone, the combination of the two has a synergistic effect on controlling blood sugar.
Glimepiride Tablets
Indication: Used for type 2 diabetes mellitus in which diet, physical exercise and weight loss cannot satisfactorily control blood sugar.
Manufacturer:
Chongqing Kangke'er Pharmaceutical Co., Ltd.
Glimepiride Tablets
Indication: Used for type 2 diabetes mellitus in which diet, physical exercise and weight loss cannot satisfactorily control blood sugar.
Manufacturer:
Chongqing Kangke'er Pharmaceutical Co., Ltd.
Glimepiride Tablets
Indication: Used for type 2 diabetes mellitus in which diet, physical exercise and weight loss cannot satisfactorily control blood sugar.
Manufacturer:
Shandong Dyne Marine Organism Pharmaceutical Co., Ltd.
Glipizide Tablets
Indication: It is suitable for patients with mild to moderate type 2 diabetes who have not achieved satisfactory results with diet control and physical exercise for 2 to 3 months. The pancreatic islet cells of such diabetic patients must have a certain insulin secretion function, and have no acute complications (such as infection, trauma, ketoacidosis, hyperosmolar coma, etc.), no pregnancy, and no serious chronic complications.
Glipizide Tablets
Indication: It is suitable for patients with mild to moderate type 2 diabetes who have not achieved satisfactory results after 2 to 3 months of diet control and physical exercise. The pancreatic islet b cells of such diabetic patients must have a certain insulin secretion function, and have no acute complications (such as infection, trauma, ketoacidosis, hyperosmolar coma, etc.), no pregnancy, and no serious chronic complications.
Glipizide Tablets
Indication: It is suitable for patients with mild to moderate type 2 diabetes who have not achieved satisfactory results after 2 to 3 months of diet control and physical exercise. The pancreatic islet b cells of such diabetic patients must have a certain insulin secretion function, and have no acute complications (such as infection, trauma, ketoacidosis, hyperosmolar coma, etc.), no pregnancy, and no serious chronic complications.
Manufacturer:
Tianjin Zhongtian Pharmaceutical Co., Ltd.
Glibenclamide Tablets
Indication: It is suitable for mild and moderate type 2 diabetes mellitus where diet alone has unsatisfactory effects. The patient's pancreatic b cells have a certain insulin secretion function and there are no serious complications.
Manufacturer:
Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd.
Gliclazide Tablets
Indication: Used for type 2 diabetes.
Thirst-quenching and blood sugar-lowering capsules
Manufacturer:
Beijing Tongrentang Co., Ltd. Tongrentang Pharmaceutical Factory